Leiomyosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
Conditions:   LMS - Leiomyosarcoma;   Uterine Leiomyosarcoma Interventions:   Drug: Gemcitabine;   Drug: Dacarbazine;   Procedure: Cytoreductive Surgery;   Behavioral: Functional Assessment of Cancer Therapy (FACT) G questionnaire;   Procedure: Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) Scan;   Drug: Gadolinium Sponsor:   Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2021 Category: Research Source Type: clinical trials

A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Condition:   Leiomyosarcoma Intervention:   Drug: Rucaparib in combination with Nivolumab Sponsors:   Memorial Sloan Kettering Cancer Center;   Bristol-Myers Squibb;   Clovis Oncology, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2020 Category: Research Source Type: clinical trials